ZNF423 and Insulin resistance: The gene product of ZNF423 promotes the transformation of non-adipocytes into adipocytes and inhibits subcutaneous adipogenesis, leading to adipocyte hypertrophy and inflammation, and finally developing to obesity and insulin resistance [30].